The researchers engineered a compound that kills leukemia cells with potency comparable to FDA-approved therapies by ...

The medicines have dangerous potency levels, either too low to fight cancer effectively or so high such that they poison ...

With an integrated platform focusing on regenerative medicine, Gwo Xi has established a PIC/S GMP-grade cell preparation ...

Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and ...

In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

Confocal z-stack image a T cell on the 0.5-4-0.5 surface, showing the cell membrane in red, nucleus in blue and the pillar surface in gray. Image is 18x18 μm in size and 2.5 μm in height.

When Good Cell Death Goes Bad That first wave of necrosis can spark what researchers call “positive feedback loops,” which are new cells rupture, inflammation deepens, and tissue starts to scar. The ...

Disease area: Oncology Lead candidate: VT3989 Recent news: Raised $35 million in series D funding Small molecule drug discovery company Vivace Therapeutics is developing cancer therapies targeting the ...

During gastrulation, mesodermal cells derived from distinct regions are destined to acquire specific cardiac fates after undergoing complex migratory movements. Here, we used light-sheet imaging of ...

TruCytes Potency cell mimics offer a customizable, scalable, and efficient alternative to cell line target cells. This helps CAR-T developers accelerate assay validation and lot release, while ...